Home
>
National Drug Code (NDC)
>
Doxorubicin Hydrochloride
Doxorubicin Hydrochloride - 47335-049-40 - (Doxorubicin Hydrochloride)
Drug Information of Doxorubicin Hydrochloride
| Product NDC: | 47335-049 |
| Proprietary Name: | Doxorubicin Hydrochloride |
| Non Proprietary Name: | Doxorubicin Hydrochloride |
| Active Ingredient(s): | 2 mg/mL & nbsp; Doxorubicin Hydrochloride |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTABLE, LIPOSOMAL |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Doxorubicin Hydrochloride
| Product NDC: | 47335-049 |
| Labeler Name: | Sun Pharma Global FZE |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA203263 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130205 |
Package Information of Doxorubicin Hydrochloride
| Package NDC: | 47335-049-40 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 PACKAGE (47335-049-40) > 10 mL in 1 VIAL, SINGLE-USE |
NDC Information of Doxorubicin Hydrochloride
| NDC Code | 47335-049-40 |
| Proprietary Name | Doxorubicin Hydrochloride |
| Package Description | 1 VIAL, SINGLE-USE in 1 PACKAGE (47335-049-40) > 10 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 47335-049 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Doxorubicin Hydrochloride |
| Dosage Form Name | INJECTABLE, LIPOSOMAL |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20130205 |
| Marketing Category Name | ANDA |
| Labeler Name | Sun Pharma Global FZE |
| Substance Name | DOXORUBICIN HYDROCHLORIDE |
| Strength Number | 2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |
